11-36574490-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000448.3(RAG1):c.1186C>T(p.Arg396Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000359 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R396L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000448.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAG1 | NM_000448.3 | c.1186C>T | p.Arg396Cys | missense_variant | 2/2 | ENST00000299440.6 | NP_000439.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAG1 | ENST00000299440.6 | c.1186C>T | p.Arg396Cys | missense_variant | 2/2 | 1 | NM_000448.3 | ENSP00000299440 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250660Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135696
GnomAD4 exome AF: 0.0000376 AC: 55AN: 1461872Hom.: 0 Cov.: 36 AF XY: 0.0000399 AC XY: 29AN XY: 727236
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74392
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Sep 05, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2023 | Published functional studies demonstrate a damaging effect with decreased V(D)J recombination activity (PMID: 24290284); This variant is associated with the following publications: (PMID: 11971977, 20956421, 11213808, 28783691, 10606976, 17075247, 25976673, 20109747, 11133745, 32000930, 32445296, 33193364, 34134972, 24290284, 26996199, 27825771, 9630231, 32655540, 30290665) - |
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Histiocytic medullary reticulosis Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 14, 2017 | Variant summary: The RAG1 c.1186C>T (p.Arg396Cys) variant located in the homeodomain, DNA binding domain involves the alteration of a conserved nucleotide and is predicted to be damaging by 4/4 in-silico functional prediction tools (SNPs&GO not captured due to low reliability index). This variant is absent in 120606 control chromosomes including broad and large populations of ExAC. This variant has been reported in patients with atypical SCID, Omenn syndrome, or RAG1-related immunodeficiency in compound heterozygous state with other missense variants as well as in a homozygous state including evidence of cosegregation with disease. One functional study shows that this variant leads to severe decrease in VDJ recombination (Lee_2014). Two other missense variants at this codon, R396L and R396H, are also found in patients with RAG1-related phenotypes and lead to severe decrease in VDJ recombination (Lee_2014), suggesting that codon Arg396 is a mutational hot-spot. Taken together, this variant is classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 29, 1998 | - - |
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 396 of the RAG1 protein (p.Arg396Cys). This variant is present in population databases (rs104894289, gnomAD 0.002%). This missense change has been observed in individual(s) with combined immunodeficiency and/or Omenn syndrome (PMID: 9630231, 32000930, 32655540, 33193364). ClinVar contains an entry for this variant (Variation ID: 13144). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RAG1 protein function. This variant disrupts the p.Arg396 amino acid residue in RAG1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9630231, 17075247, 19830075). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Combined immunodeficiency due to partial RAG1 deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 05, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at